Wellgistics Health (WGRX) Stock Price, News & Analysis

Company Overview

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. We are focused on improving the lives of patients while delivering unique solutions for pharmacies, providers, pharmaceutical manufacturers, and payors. In January 2023 and May 2023, Wellgistics Health entered into separate definitive agreements with the owners of Wood Sage and Wellgistics LLC, respectively, whereby Wellgistics Health would acquire all of the respective outstanding membership interests of Wood Sage and Wellgistics LLC. In June 2024, Wellgistics Health and Wood Sage entered into an amended and revised definitive agreement and closed on the Wood Sage Acquisition, thereby making Wood Sage a wholly owned subsidiary of Wellgistics Health. In connection with the Wood Sage Acquisition, Wellgistics Health acquired Wood Sage’s two operating subsidiaries, APS—a pharmaceutical technology hub—and CSP—a retail community specialty pharmacy. On August 30, 2024, Wellgistics Health closed on the Wellgistics Acquisition, thereby making Wellgistics LLC—a company focused on wholesale operations including the distribution and fulfillment of certain pharmaceutical medications to a network of independent pharmacies meant to improve market access to and patient outcomes regarding the medications—a wholly owned subsidiary of Wellgistics Health. As such, Wellgistics Health currently exists as a holding company with Wood Sage as a directly held intermediate holding company subsidiary, APS and CSP as indirect operating subsidiaries, and Wellgistics LLC as a direct operating subsidiary. On October 4, 2024, the Company changed its corporate name to “Wellgistics Health, Inc.” by filing a duly authorized Certificate of Amendment to its Certificate of Incorporation. Despite that Wellgistics Health only recently closed the Wood Sage Acquisition and the Wellgistics Acquisition during 2024, the three companies have shared common office space, comarketed solutions to the marketplace, and leveraged financial and back-office support prior to June 2024. As such, Wellgistics Health’s management believes that its close business relationships have and will continue to limit the need for post-closing integration. The mailing address of our principal executive office is 3000 Bayport Drive, Suite 950 Tampa, FL.

Key Stats

• Today's Range: $0.85 to $0.97
• 50-Day Range: N/A
• 52-Week Range: $0.75 to $7.04
• Volume: 545,548 shs
• Average Volume: 685,460 shs
• Market Capitalization: $66.56 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WGRX Stock Analysis - Frequently Asked Questions

How have WGRX shares performed this year?

Wellgistics Health's stock was trading at $1.33 at the start of the year. Since then, WGRX shares have decreased by 33.9% and is now trading at $0.8790.

When did Wellgistics Health IPO?

Wellgistics Health (WGRX) raised $4 million in an initial public offering (IPO) on Friday, February 21st 2025. The company issued 900,000 shares at $4.50-$5.50 per share. Craft Capital and D. Boral Capital (ex-EF Hutton) served as the underwriters for the IPO.

When does the company's lock-up period expire?

Wellgistics Health's lock-up period expires on Wednesday, August 20th. Wellgistics Health had issued 888,889 shares in its public offering on February 21st. The total size of the offering was $4,000,001 based on an initial share price of $4.50. After the expiration of the company's lock-up period, restrictions preventing major shareholders and company insiders from selling shares in the company will be lifted.

How do I buy shares of Wellgistics Health?

Shares of WGRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

• Today: 7/29/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: Wholesale
• Current Symbol: NASDAQ:WGRX
• CIK: 2030763
• Web: N/A
• Phone: 1-843-302-1785
• Fax: N/A
• Employees: 31
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 1.43
• Current Ratio: 0.36
• Quick Ratio: 0.15

Sales & Book Value

• Annual Sales: $28.99 million
• Price / Sales: 2.30
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 75,721,000
• Free Float: N/A
• Market Cap: $66.56 million
• Optionable: N/A
• Beta: N/A